STEPHANIE LAJEUNESSE: Open Payments
NPI 1053855080 · WEST HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,548 in 62 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,548
Food & beverage: $1,548
| Company | Payments | Amount |
|---|---|---|
| CSL Behring | 5 | $206 |
| GENZYME CORPORATION | 9 | $190 |
| Novartis Pharmaceuticals Corporation | 9 | $170 |
| AstraZeneca Pharmaceuticals LP | 6 | $166 |
| GlaxoSmithKline, LLC. | 5 | $126 |
| Regeneron Healthcare Solutions, Inc. | 3 | $89 |
| Organon LLC | 3 | $81 |
| Grifols USA, LLC | 3 | $78 |
| Amgen Inc. | 3 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $70 |
Products named: Hizentra, DUPIXENT, Xolair, TEZSPIRE, NUCALA, FASENRA, CUVITRU, Prolastin-C Liquid.
Industry payments across CT — which companies pay providers there.
